Literature DB >> 16949256

Discordance of meropenem versus imipenem activity against Acinetobacter baumannii.

Alexandros Ikonomidis, Spyros Pournaras, Antonios N Maniatis, Nicholas J Legakis, Athanassios Tsakris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16949256     DOI： 10.1016/j.ijantimicag.2006.07.007

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  6 in total

1.  Acinetobacter baumannii: A Brief Account of Mechanisms of Multidrug Resistance and Current and Future Therapeutic Management.

Authors:  Harmanjit Singh; Pugazhenthan Thangaraj; Amitava Chakrabarti
Journal:  J Clin Diagn Res       Date:  2013-11-10

2.  Comparative pharmacodynamics of four different carbapenems in combination with polymyxin B against carbapenem-resistant Acinetobacter baumannii.

Authors:  Justin R Lenhard; Jonathan S Gall; Jurgen B Bulitta; Visanu Thamlikitkul; Cornelia B Landersdorfer; Alan Forrest; Roger L Nation; Jian Li; Brian T Tsuji
Journal:  Int J Antimicrob Agents       Date:  2016-09-20       Impact factor: 5.283

3.  Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy.

Authors:  Silvia D'Arezzo; Luigi Principe; Alessandro Capone; Nicola Petrosillo; Andrea Petrucca; Paolo Visca
Journal:  J Antimicrob Chemother       Date:  2010-11-18       Impact factor: 5.790

Review 4.  Treatment options for multidrug-resistant Acinetobacter species.

Authors:  Jacob Gilad; Yehuda Carmeli
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  Influence of Concentration and Temperature on Stability of Imipenem Focused on Solutions for Extended Infusion.

Authors:  Chuleegone Sornsuvit; Purida Wientong; Suriyon Uitrakul; Siriporn Okonogi; Wasan Katip
Journal:  Dose Response       Date:  2021-11-23       Impact factor: 2.658

6.  An Evidence-Based Multidisciplinary Approach Focused on Creating Algorithms for Targeted Therapy of Infection-Related Ventilator-Associated Complications (IVACs) Caused by Pseudomonas aeruginosa and Acinetobacter baumannii in Critically Ill Adult Patients.

Authors:  Milo Gatti; Bruno Viaggi; Gian Maria Rossolini; Federico Pea; Pierluigi Viale
Journal:  Antibiotics (Basel)       Date:  2021-12-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.